Anti-latent TGFβ binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy.

MLA

Demonbreun, Alexis R., et al. “Anti-Latent TGFβ Binding Protein 4 Antibody Improves Muscle Function and Reduces Muscle Fibrosis in Muscular Dystrophy.” Science Translational Medicine, vol. 13, no. 610, Sept. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1126/scitranslmed.abf0376.

APA

Demonbreun, A. R., Fallon, K. S., Oosterbaan, C. C., Vaught, L. A., Reiser, N. L., Bogdanovic, E., Velez, M. P., Salamone, I. M., Page, P. G. T., Hadhazy, M., Quattrocelli, M., Barefield, D. Y., Wood, L. D., Gonzalez, J. P., Morris, C., & McNally, E. M. (2021). Anti-latent TGFβ binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy. Science Translational Medicine, 13(610), 1–11. https://doi.org/10.1126/scitranslmed.abf0376

Chicago

Demonbreun, Alexis R., Katherine S. Fallon, Claire C. Oosterbaan, Lauren A. Vaught, Nina L. Reiser, Elena Bogdanovic, Matthew P. Velez, et al. 2021. “Anti-Latent TGFβ Binding Protein 4 Antibody Improves Muscle Function and Reduces Muscle Fibrosis in Muscular Dystrophy.” Science Translational Medicine 13 (610): 1–11. doi:10.1126/scitranslmed.abf0376.